Tasha K. Ritchie

1.4k total citations · 1 hit paper
13 papers, 1.1k citations indexed

About

Tasha K. Ritchie is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Tasha K. Ritchie has authored 13 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Pediatrics, Perinatology and Child Health and 4 papers in Infectious Diseases. Recurrent topics in Tasha K. Ritchie's work include Drug Transport and Resistance Mechanisms (12 papers), Pharmacological Effects and Toxicity Studies (9 papers) and HIV/AIDS drug development and treatment (4 papers). Tasha K. Ritchie is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Pharmacological Effects and Toxicity Studies (9 papers) and HIV/AIDS drug development and treatment (4 papers). Tasha K. Ritchie collaborates with scholars based in United States, United Kingdom and France. Tasha K. Ritchie's co-authors include William M. Atkins, Joseph K. Zolnerciks, Ilia G. Denisov, Stephen G. Sligar, Timothy H. Bayburt, Yelena V. Grinkova, Isabelle Ragueneau‐Majlessi, Jingjing Yu, Hye-Won Kwon and Lanxiang Wu and has published in prestigious journals such as Journal of Biological Chemistry, Methods in enzymology on CD-ROM/Methods in enzymology and Pharmacology & Therapeutics.

In The Last Decade

Tasha K. Ritchie

13 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reconstitution of Membrane Proteins in Phospholipid Bilayer Nanodiscs

2009 673 citations Tasha K. Ritchie, Yelena V. Grinkova et al. Methods in enzymology on CD-ROM/Methods in enzymology profile →

Peers

Countries citing papers authored by Tasha K. Ritchie

Since Specialization

Citations

This map shows the geographic impact of Tasha K. Ritchie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tasha K. Ritchie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tasha K. Ritchie more than expected).

Fields of papers citing papers by Tasha K. Ritchie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tasha K. Ritchie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tasha K. Ritchie. The network helps show where Tasha K. Ritchie may publish in the future.

Co-authorship network of co-authors of Tasha K. Ritchie

This figure shows the co-authorship network connecting the top 25 collaborators of Tasha K. Ritchie. A scholar is included among the top collaborators of Tasha K. Ritchie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tasha K. Ritchie. Tasha K. Ritchie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Inhibitors of Organic Anion‐Transporting Polypeptides 1B1 and 1B3: Clinical Relevance and Regulatory Perspective 2020 ·The Journal of Clinical Pharmacology ·(unknown), Tasha K. Ritchie, Jingjing Yu, Anna Nordmark, Eva Gil Berglund, René H. Levy, Isabelle Ragueneau‐Majlessi	4
2	Identification and Evaluation of Clinical Substrates of Organic Anion Transporting Polypeptides 1B1 and 1B3 2019 ·Clinical and Translational Science ·(unknown), Tasha K. Ritchie, Jingjing Yu, Anna Nordmark, René H. Levy, Isabelle Ragueneau‐Majlessi	18
3	Variability in In Vitro OATP1B1/1B3 Inhibition Data: Impact of Incubation Conditions on Variability and Subsequent Drug Interaction Predictions 2019 ·Clinical and Translational Science ·(unknown), Tasha K. Ritchie, Isabelle Ragueneau‐Majlessi	9
4	Organic anion transporting polypeptide 2B1 – More than a glass-full of drug interactions 2018 ·Pharmacology & Therapeutics ·(unknown), Lanxiang Wu, Tasha K. Ritchie, Jashvant D. Unadkat	52
5	Identification and evaluation of clinical substrates of organic anion transporting polypeptides 1B1 and 1B3 2018 ·Drug Metabolism and Pharmacokinetics ·(unknown), Tasha K. Ritchie, Jingjing Yu, Eva Gil Berglund, Anna Nordmark, Isabelle Ragueneau‐Majlessi	1
6	Investigating ABCB1-Mediated Drug-Drug Interactions: Considerations for In vitro and In vivo Assay Design 2016 ·Current Drug Metabolism ·(unknown), (unknown), Tasha K. Ritchie, Gábor Imre, Károly Mogyorósi, (unknown), (unknown), (unknown), (unknown), (unknown), Joseph K. Zolnerciks, Krisztina Herédi‐Szabó, Isabelle Ragueneau‐Majlessi, Péter Krajcsi	3
7	What Can Be Learned from Recent New Drug Applications? A Systematic Review of Drug Interaction Data for Drugs Approved by the US FDA in 2015 2016 ·Drug Metabolism and Disposition ·Jingjing Yu, Zhu Zhou, (unknown), Tasha K. Ritchie, Isabelle Ragueneau‐Majlessi	38
8	Breast Cancer Resistance Protein (ABCG2) in Clinical Pharmacokinetics and Drug Interactions: Practical Recommendations for Clinical Victim and Perpetrator Drug-Drug Interaction Study Design 2015 ·Drug Metabolism and Disposition ·Caroline A. Lee, (unknown), Tasha K. Ritchie, Aleksandra Galetin, Jack Cook, Isabelle Ragueneau‐Majlessi, Harma Ellens, Bo Feng, Mitchell E. Taub, Mary F. Paine, Joseph W. Polli, Joseph A. Ware, Maciej J. Zamek‐Gliszczynski	108
9	Key Findings from Preclinical and Clinical Drug Interaction Studies Presented in New Drug and Biological License Applications Approved by the Food and Drug Administration in 2014 2015 ·Drug Metabolism and Disposition ·Jun Yu, Tasha K. Ritchie, Zhenyu Zhou, Isabelle Ragueneau‐Majlessi	31
10	The multidrug resistance pump ABCB1 is a substrate for the ubiquitin ligase NEDD4-1 2015 ·Molecular Membrane Biology ·(unknown), Joseph K. Zolnerciks, Tasha K. Ritchie, Bjoern Bauer, Anika M. S. Hartz, James A. Sullivan, Kenneth J. Linton	27
11	Drug Disposition and Drug-Drug Interaction Data in 2013 FDA New Drug Applications: A Systematic Review 2014 ·Drug Metabolism and Disposition ·Jingjing Yu, Tasha K. Ritchie, Aditi Mulgaonkar, Isabelle Ragueneau‐Majlessi	42
12	Conformational Analysis of Human ATP-binding Cassette Transporter ABCB1 in Lipid Nanodiscs and Inhibition by the Antibodies MRK16 and UIC2 2011 ·Journal of Biological Chemistry ·Tasha K. Ritchie, Hye-Won Kwon, William M. Atkins	62
13	Reconstitution of Membrane Proteins in Phospholipid Bilayer Nanodiscs breakdown → 2009 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Tasha K. Ritchie, Yelena V. Grinkova, Timothy H. Bayburt, Ilia G. Denisov, Joseph K. Zolnerciks, William M. Atkins, Stephen G. Sligar	673

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact